165 related articles for article (PubMed ID: 28087642)
1. STXBP4 Drives Tumor Growth and Is Associated with Poor Prognosis through PDGF Receptor Signaling in Lung Squamous Cell Carcinoma.
Otaka Y; Rokudai S; Kaira K; Fujieda M; Horikoshi I; Iwakawa-Kawabata R; Yoshiyama S; Yokobori T; Ohtaki Y; Shimizu K; Oyama T; Tamura J; Prives C; Nishiyama M
Clin Cancer Res; 2017 Jul; 23(13):3442-3452. PubMed ID: 28087642
[No Abstract] [Full Text] [Related]
2. Distinctive roles of syntaxin binding protein 4 and its action target, TP63, in lung squamous cell carcinoma: a theranostic study for the precision medicine.
Bilguun EO; Kaira K; Kawabata-Iwakawa R; Rokudai S; Shimizu K; Yokobori T; Oyama T; Shirabe K; Nishiyama M
BMC Cancer; 2020 Sep; 20(1):935. PubMed ID: 32993587
[TBL] [Abstract][Full Text] [Related]
3. STXBP4 regulates APC/C-mediated p63 turnover and drives squamous cell carcinogenesis.
Rokudai S; Li Y; Otaka Y; Fujieda M; Owens DM; Christiano AM; Nishiyama M; Prives C
Proc Natl Acad Sci U S A; 2018 May; 115(21):E4806-E4814. PubMed ID: 29735662
[TBL] [Abstract][Full Text] [Related]
4. Regulation of TPD52 by antitumor microRNA-218 suppresses cancer cell migration and invasion in lung squamous cell carcinoma.
Kumamoto T; Seki N; Mataki H; Mizuno K; Kamikawaji K; Samukawa T; Koshizuka K; Goto Y; Inoue H
Int J Oncol; 2016 Nov; 49(5):1870-1880. PubMed ID: 27633630
[TBL] [Abstract][Full Text] [Related]
5. Dual-strand tumor-suppressor microRNA-145 (miR-145-5p and miR-145-3p) coordinately targeted MTDH in lung squamous cell carcinoma.
Mataki H; Seki N; Mizuno K; Nohata N; Kamikawaji K; Kumamoto T; Koshizuka K; Goto Y; Inoue H
Oncotarget; 2016 Nov; 7(44):72084-72098. PubMed ID: 27765924
[TBL] [Abstract][Full Text] [Related]
6. Long noncoding RNA LINC00511 involves in breast cancer recurrence and radioresistance by regulating STXBP4 expression via miR-185.
Liu L; Zhu Y; Liu AM; Feng Y; Chen Y
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7457-7468. PubMed ID: 31539133
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Role of the FGFR4-388Arg Variant in Lung Squamous-Cell Carcinoma Patients With Lymph Node Involvement.
Quintanal-Villalonga Á; Carranza-Carranza A; Meléndez R; Ferrer I; Molina-Pinelo S; Paz-Ares L
Clin Lung Cancer; 2017 Nov; 18(6):667-674.e1. PubMed ID: 28583379
[TBL] [Abstract][Full Text] [Related]
8. Tumor-suppressive microRNA-206 as a dual inhibitor of MET and EGFR oncogenic signaling in lung squamous cell carcinoma.
Mataki H; Seki N; Chiyomaru T; Enokida H; Goto Y; Kumamoto T; Machida K; Mizuno K; Nakagawa M; Inoue H
Int J Oncol; 2015 Mar; 46(3):1039-50. PubMed ID: 25522678
[TBL] [Abstract][Full Text] [Related]
9. GLI1 Blockade Potentiates the Antitumor Activity of PI3K Antagonists in Lung Squamous Cell Carcinoma.
Kasiri S; Shao C; Chen B; Wilson AN; Yenerall P; Timmons BC; Girard L; Tian H; Behrens C; Wistuba II; Gazdar AF; Kim J
Cancer Res; 2017 Aug; 77(16):4448-4459. PubMed ID: 28652248
[TBL] [Abstract][Full Text] [Related]
10. FGFR1 gene amplification in squamous cell carcinomas of the lung: a potential favorable prognostic marker for women and for patients with advanced cancer.
Flockerzi FA; Roggia C; Langer F; Holleczek B; Bohle RM
Virchows Arch; 2018 May; 472(5):759-769. PubMed ID: 29270870
[TBL] [Abstract][Full Text] [Related]
11. Tumor suppressive microRNA-133a regulates novel molecular networks in lung squamous cell carcinoma.
Moriya Y; Nohata N; Kinoshita T; Mutallip M; Okamoto T; Yoshida S; Suzuki M; Yoshino I; Seki N
J Hum Genet; 2012 Jan; 57(1):38-45. PubMed ID: 22089643
[TBL] [Abstract][Full Text] [Related]
12. More expression of BDNF associates with lung squamous cell carcinoma and is critical to the proliferation and invasion of lung cancer cells.
Zhang SY; Hui LP; Li CY; Gao J; Cui ZS; Qiu XS
BMC Cancer; 2016 Feb; 16():171. PubMed ID: 26926340
[TBL] [Abstract][Full Text] [Related]
13. Claudin-1 Protein Expression Is a Good Prognostic Factor in Non-Small Cell Lung Cancer, but only in Squamous Cell Carcinoma Cases.
Moldvay J; Fábián K; Jäckel M; Németh Z; Bogos K; Furák J; Tiszlavicz L; Fillinger J; Döme B; Schaff Z
Pathol Oncol Res; 2017 Jan; 23(1):151-156. PubMed ID: 27687058
[TBL] [Abstract][Full Text] [Related]
14. Tyr1068-phosphorylated epidermal growth factor receptor (EGFR) predicts cancer stem cell targeting by erlotinib in preclinical models of wild-type EGFR lung cancer.
Sette G; Salvati V; Mottolese M; Visca P; Gallo E; Fecchi K; Pilozzi E; Duranti E; Policicchio E; Tartaglia M; Milella M; De Maria R; Eramo A
Cell Death Dis; 2015 Aug; 6(8):e1850. PubMed ID: 26247735
[TBL] [Abstract][Full Text] [Related]
15. Sex-Determining Region Y-box 2 Promotes Growth of Lung Squamous Cell Carcinoma and Directly Targets Cyclin D1.
Li C; He B; Huang C; Yang H; Cao L; Huang J; Hu C
DNA Cell Biol; 2017 Apr; 36(4):264-272. PubMed ID: 28151013
[TBL] [Abstract][Full Text] [Related]
16. miR-448 is a novel prognostic factor of lung squamous cell carcinoma and regulates cells growth and metastasis by targeting DCLK1.
Shan C; Fei F; Li F; Zhuang B; Zheng Y; Wan Y; Chen J
Biomed Pharmacother; 2017 May; 89():1227-1234. PubMed ID: 28320089
[TBL] [Abstract][Full Text] [Related]
17. Increased PTPRA expression leads to poor prognosis through c-Src activation and G1 phase progression in squamous cell lung cancer.
Gu Z; Fang X; Li C; Chen C; Liang G; Zheng X; Fan Q
Int J Oncol; 2017 Aug; 51(2):489-497. PubMed ID: 28656243
[TBL] [Abstract][Full Text] [Related]
18. Stxbp4 regulates DeltaNp63 stability by suppression of RACK1-dependent degradation.
Li Y; Peart MJ; Prives C
Mol Cell Biol; 2009 Jul; 29(14):3953-63. PubMed ID: 19451233
[TBL] [Abstract][Full Text] [Related]
19. Squalene epoxidase promotes the proliferation and metastasis of lung squamous cell carcinoma cells though extracellular signal-regulated kinase signaling.
Ge H; Zhao Y; Shi X; Tan Z; Chi X; He M; Jiang G; Ji L; Li H
Thorac Cancer; 2019 Mar; 10(3):428-436. PubMed ID: 30734525
[TBL] [Abstract][Full Text] [Related]
20. 14-3-3ζ/TGFβR1 promotes tumor metastasis in lung squamous cell carcinoma.
Zhao Y; Qiao W; Wang X; Yin H; Cui J; Cui Y; Chen X; Hu J; Lu H; Meng Q; Wang Y; Cai L
Oncotarget; 2016 Dec; 7(50):82972-82984. PubMed ID: 27764818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]